The ability to diagnose at a point-of-care setting will help with more quickly and appropriately treating sexually-transmitted infections, expert says.
FDA has provided information on specific molecular tests impacted by viral mutations, and recommendations for those tests.
Hilden, Germany-based Qiagen inherited the test when it acquired the remaining stake in NeuMoDx Molecular for $248 million in 2020. The NeuMoDx assay's Emergency Use Authorization comes at a time when developments in COVID-19-related tests are...
Pressed for time? Here's the medtech news you need most, in one minute or less.
Part one of a three-part series on diagnostics explores how the COVID-19 pandemic is changing healthcare customers.
Everlywell and Vault Health enlist DoorDash to help deliver COVID-19 PCR test collection kits.
A deep-dive into how the pandemic turned an evolution into a revolution — and what to expect the future of diagnostic testing to look like.